In conclusion, there is compelling evidence that the BM microenvironment-mediated expression of several TFs, such as c-MYC, JunB and c-MAF, and the modulation of chromatin condensation can mediate drug resistance in MM, envisioning a possible targeting of these molecules in the anti-MM armamentarium. This evidence concerns the gene MYC and Miyoshi myopathy.